Authors

• Yap‐Hang Chan (ORCID: https://orcid.org/0000-0001-5384-8468)
• Ian B. Wilkinson (ORCID: https://orcid.org/0000-0001-6598-9399)
• Joseph Cheriyan (ORCID: https://orcid.org/0000-0001-6921-1592)
• Tak Mao Chan (ORCID: https://orcid.org/0000-0002-3495-4051)
• Hung‐Fat Tse (ORCID: https://orcid.org/0000-0002-9578-7808)
• H Y Li
• Kai‐Hang Yiu

Institutions

• Hong Kong Baptist University (HK)
• University of Cambridge (GB)
• Royal Papworth Hospital (GB)
• Queen Mary Hospital (CN)
• Cambridge University Hospitals NHS Foundation Trust (GB)
• Bridge University (SS)
• University of Hong Kong - Shenzhen Hospital (CN)
• University of Hong Kong (HK)

Publication Details

Journal

American Journal of Cardiovascular Drugs

Published

2025-09-01

DOI

https://doi.org/10.1007/s40256-025-00743-y

Citations

3

Primary Topic

Inflammasome and immune disorders

Type

article

Field-Weighted Citation Impact

2.42

Funders

• University of Hong Kong